ClinicalTrials.Veeva

Menu

Impact of a Patient-Centered Program for Low Anterior Resection Syndrome a Multicenter Randomized Controlled Trial

J

Jewish General Hospital

Status

Completed

Conditions

Low Anterior Resection
Patient Activation
Surgery
Low Anterior Resection Syndrome
Rectal Cancer

Treatments

Other: Patient Activation Booklet and nursing support for patients with LARS

Study type

Interventional

Funder types

Other

Identifiers

NCT03828318
MP-05-2019-1628

Details and patient eligibility

About

After undergoing restorative proctectomy for rectal cancer, many patients are left with significant bowel dysfunction, known as Low Anterior Resection Syndrome (LARS). Increased LARS severity correlates with worse perceived global health status and quality of life (QoL). Among patients undergoing rectal resection with a permanent ostomy, there is evidence that supportive and educational interventions improve QoL, ostomy proficiency, self-efficacy and knowledge. However, evidence regarding the impact of such interventions in patients who undergo restorative proctectomy is lacking, despite the latter operation being far more frequently performed.

The overall goal of this study is to evaluate the extent to which a LARS Patient-Centered Program impacts on patient-reported outcome measures (PROMs) after restorative proctectomy for rectal cancer.

This is a randomized-controlled muticenter trial that will include patients who have undergone restorative proctectomy for neoplastic disease (benign or malignant) located in the rectum (0-15cm from the anal verge) with a diverting ostomy and who are scheduled for ostomy closure.

Enrollment

160 patients

Sex

All

Ages

18 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients (>=18 years-old) who have undergone restorative proctectomy for neoplastic disease (benign or malignant) located in the rectum (0-15cm from the anal verge) with a diverting ostomy and who are scheduled for ostomy closure

Exclusion criteria

  • Patients from whom clear and informed consent cannot be obtained
  • Patients unable to read and comprehend English or French
  • Patients who cannot be contacted by telephone
  • Patients who have undergone major colonic resection in addition to their proctectomy
  • Patients on active chemotherapy or radiotherapy treatment

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

160 participants in 2 patient groups

Patient Activation Arm
Experimental group
Treatment:
Other: Patient Activation Booklet and nursing support for patients with LARS
Standard Care Arm
No Intervention group

Trial contacts and locations

6

Loading...

Central trial contact

Marie Demian, Msc; Aashiyan Singh, Msc(A)

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems